Trans-resveratrol (Jupiter Orphan Therapeutics)

Tier C — Watch / trade

Jupiter Orphan Therapeutics

Originator

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：SIRT1

Brand：Jotrol, resVida

Indications (approved)：Friedreich's ataxia, Parkinson's disease, Alzheimer's disease

Regional status

Phase II

2025-11-05

China

Japan

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 1 · Total yield 160 g (Trans-resveratrol)

Trans-resveratrol501-36-0Trans-resveratrol-00126153-38-8Trans-resveratrol-00268997-88-6API · Trans-resveratrol (Jupiter Orphan Therapeutics)

Code	CAS No.	Intermediate
Trans-resveratrol	501-36-0	-
Trans-resveratrol-001	26153-38-8	3,5-dihydroxybenzaldehyde
Trans-resveratrol-002	68997-88-6	dimethyl (4-hydroxybenzyl)phosphonate

Frequently asked questions

What are the approved indications of Trans-resveratrol (Jupiter Orphan Therapeutics)?

Approved indications include: Friedreich's ataxia, Parkinson's disease, Alzheimer's disease.

When does the Trans-resveratrol (Jupiter Orphan Therapeutics) patent expire?

No public expiry year is available for Trans-resveratrol (Jupiter Orphan Therapeutics) yet; this page updates once verified.

How many synthesis routes are recorded for Trans-resveratrol (Jupiter Orphan Therapeutics)?

1 synthesis routes are recorded; the shortest is 1 steps with 160 g (Trans-resveratrol) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Trans-resveratrol (Jupiter Orphan Therapeutics) intermediates?

All intermediates in Trans-resveratrol (Jupiter Orphan Therapeutics) routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Trans-resveratrol (Jupiter Orphan Therapeutics) intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-01